spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Bristol Myers Squibb 

 HSMN NewsFeed - 3 Sep 2024
Forward Therapeutics Welcomes Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2024
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Apr 2024
Repertoire(R) Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2024
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Apr 2024
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Jan 2024
TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Dec 2023
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2023
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 28 Jun 2023
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Mar 2023
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jan 2023
ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Aug 2022
GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Apr 2022
MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics
 HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Dec 2021
FDA Approves First Drug to Prevent Graft Versus Host Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2021
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2021
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(TM) Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA
 HSMN NewsFeed - 9 Aug 2021
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2021
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2021
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
Biopharmaceutical Personnel
 HSMN NewsFeed - 14 Apr 2021
HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2021
Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 24 Feb 2021
Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Feb 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Dec 2020
Servier to Acquire Agios Pharmaceuticals' Oncology Business
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 18 Nov 2020
Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Oct 2020
Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Aug 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 May 2019
Evox Therapeutics Expands Leadership Team With the Appointment of Two Experienced Life Sciences Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2019
Portage Announces Change of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 May 2018
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Mar 2018
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 7 Aug 2017
BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Feb 2017
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
Biopharmaceutical Oncology Personnel
 HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2015
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
Devices Wound Care Personnel
 HSMN NewsFeed - 18 Dec 2014
Verastem Appoints Daniel Paterson as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2014
Novira Names Christian S. Schade Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2014
Arvinas Hires Jim Winkler as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel
 HSMN NewsFeed - 16 Oct 2013
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2013
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2013
Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Oct 2012
Amarantus BioSciences Appoints Clinton O. Allen To Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Aug 2012
Teva Pharmaceutical Announces New Appointments of President and Chief Executive Officer, Global Operations and Executive Vice President, Community and Institutional Affairs
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 28 Mar 2012
Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2011
Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2011
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2010
Faheem Hasnain Named President and Chief Executive Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jun 2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Biopharmaceuticals Generics HIV/AIDS FDA
 HSMN NewsFeed - 8 Feb 2010
KineMed Broadens Collaboration with Bristol-Myers Squibb
Biopharmaceuticals Personalized Medicine Neurology
 HSMN NewsFeed - 30 Sep 2009
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2009
Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2008
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Oct 2007
Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 30 Aug 2007
Entelos Acquires Iconix Biosciences, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2007
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 May 2007
Ranbaxy Expands its Presence in the U.S. Dermatology Market Through the Acquisition of 13 Brands from Bristol Myers Squibb
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 21 May 2007
Galenea Corp. Appoints Mark Benjamin as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2007
AEterna Zentaris Bolsters Management Team with Two Key Positions Named
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Biopharmaceuticals Generics Endocrinology FDA
 HSMN NewsFeed - 12 Feb 2007
FONAR Increases in-House Advertising Capability; Hires Creative Director of Leapfrog Communications as Vice President of Advertising
Devices Personnel
 HSMN NewsFeed - 21 Dec 2006
Data Monitoring Committee Recommends Closing Enrollment in Recurrent Glioblastoma Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Nov 2006
Use of Hyperthermia Therapy in Treating Primary and Recurrent Breast Cancer Highlights Breast Cancer Congress
Devices Oncology
 HSMN NewsFeed - 1 Nov 2006
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2006
EKR Therapeutics Expands Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 49

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 49 additional stories matching:
Bristol Myers Squibb
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.